- Open Access
Including unpublished surveys in reviews on Chagas disease in Mexico
Public Health Reviews volume 41, Article number: 24 (2020)
A consequence of the late awareness of Chagas disease in North America is that many early studies were never published in peer-reviewed journals and are not easily accessible for inclusion in systematic reviews. We reviewed data from the state of Guanajuato, Mexico, as an illustration. Three population-based surveys have been performed between 1991 and 2002 and were never fully published. Systematic reviews should recognize this publication bias.
Chagas disease or American trypanosomiasis is a major cause of cardiac disease in the Americas . Most of the efforts to control Chagas disease have been focused on South and Central America, while the awareness of Chagas disease is more recent in North America, including Mexico . A recent systematic review of Mexican population-based data from 2006 to 2017 estimated the Trypanosoma cruzi national seroprevalence at 3.4% . Historically, Mexico has been divided into “endemic” and “non-endemic” areas for Chagas disease . There is now a growing consensus that Chagas disease is a national problem in Mexico, regardless of the federal entity.
A consequence of the late awareness of Chagas disease in North America is that many early studies were never published in peer-reviewed journals and are not easily accessible for inclusion in systematic reviews. We will review data from the state of Guanajuato as an illustration. The state of Guanajuato is north of Mexico City and is one of the states sending more immigrants to the USA . Detailed entomological studies have shown that the vector is present all over the state [5, 6]. Three population-based surveys have been performed between 1991 and 2002 and were never fully published. A serological survey performed by Juárez Leyva in 1991 in San José de la Presa, Purísima del Rincón, Guanajuato, found a T. cruzi seroprevalence of 6.1% (n = 228) [5, 7]. Another serological survey performed in Guanajuato in 1999–2000 in 60 communities found a seroprevalence of 2.6% (n = 1730) . A serological survey performed in Ciudad Manuel Doblado, Guanajuato, in 2002, found 2.0% seroprevalence among 200 children and adolescents < 18 years old . Studies performed more recently were published and showed seroprevalence of 0.8% in Celaya, Guanajuato, in 2006–2007 and of 3.8% in León, Guanajuato, in 2014–2015 [8, 9]. The reported number of cases of Chagas disease from Guanajuato increased over time, suggesting a growing awareness of the disease .
Many studies on Chagas disease in Mexico were most likely not published in peer-reviewed journals. Systematic reviews should recognize this publication bias and search for unpublished data as much as possible.
Availability of data and materials
Arnal A, Waleckx E, Rico-Chávez O, Herrera C, Dumonteil E. Estimating the current burden of Chagas disease in Mexico: a systematic review and meta-analysis of epidemiological surveys from 2006 to 2017. Plos Negl Trop Dis. 2019;13(4):e0006859.
Buekens P, Almendares O, Carlier Y, Dumonteil E, Eberhard M, Gamboa-Leon R, et al. Mother-to-child transmission of Chagas’ disease in North America: why don’t we do more? Matern Child Health J. 2008;12(3):283–6.
Novelo-Garza BA, Benítez-Arvizu G, Peña-Benítez A, Galván-Cervantes J, Morales-Rojas A. Detection of Trypanosoma cruzi in blood donors. Rev Med Inst Mex Seguro Soc. 2010;48(2):139–44.
Yearbook of migration and remittances Mexico. Mexico City: CONAPO Consejo Nacional de Población; 2018.
López-Cárdenas J, Gonzalez Bravo FE, Salazar Schettino PM, Gallaga Solorzano JC, Ramírez Barba E, Martinez Mendez J, et al. Fine-scale predictions of distributions of Chagas disease vectors in the state of Guanajuato, Mexico. J Med Entomol. 2005;42(6):1068–81.
Salazar Schettino PM, Rosales Piña JS, Rojas Wastavino G, Cabrera Bravo M, Vences Blanco M, López CJ. Triatoma mexicana (Hemiptera: Reduviidae) in Guanajuato, Mexico: house infestation and seasonal variation. Mem Inst Oswaldo Cruz. 2007;102(7):803–7.
Peña-Archundia G. Estudio de la distribución espacial y parasitosis del vector de la enfermedad de Chagas y su seroprevalencia en menores de 18 años en el municipio de Manuel Doblado, estado de Guanajuato, del 2001 al 2003. León, Guanajuato: Universidad de Guanajuato; 2005.
Montes-Rincón LM, Galaviz-Silva L, González-Bravo FE, Molina-Garza ZJ. Trypanosoma cruzi seroprevalence in pregnant women and screening by PCR and microhaematocrit in newborns from Guanajuato, Mexico. Acta Trop. 2016;164:100–6.
Gamboa-León R, Gonzalez-Ramirez C, Padilla-Raygoza N, Sosa-Estani S, Caamal-Kantun A, Buekens P, et al. Do commercial serologic tests for Trypanosoma cruzi infection detect Mexican strains in women and newborns? J Parasitol. 2011;97(2):338–43.
Shelly EM, Acuna-Soto R, Ernst KC, Sterling CR, Brown HE. A critical assessment of officially reported Chagas disease surveillance data in Mexico. Public Health Rep. 2016;131(1):59–66.
We thank Andrea Meyer for her help in editing the manuscript.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Buekens, P., López-Cárdenas, J., Dumonteil, E. et al. Including unpublished surveys in reviews on Chagas disease in Mexico. Public Health Rev 41, 24 (2020). https://doi.org/10.1186/s40985-020-00140-7
- Chagas disease
- Trypanosoma cruzi